Filtered By:
Condition: Bleeding
Cancer: Squamous Cell Carcinoma
This page shows you your search results in order of date.
Order by Relevance | Date
Total 89 results found since Jan 2013.
Successful Shrinkage of a Giant Cutaneous Squamous Cell Carcinoma with Immunotherapy in a Kidney Transplant Recipient
Exp Clin Transplant. 2023 Jun;21(6):534-536. doi: 10.6002/ect.2023.0018.ABSTRACTA 56-year-old male living donor kidney transplant recipient presented with a giant cutaneous squamous cell carcinoma in his right parotid region. Programmed radiotherapy had been previously terminated due to lesion ulceration and bleeding. He was characterized as a terminal case. We applied cemiplimab, which is an immune checkpoint inhibitor against the pro-grammed cell death receptor PD-1. After 6 months, the cutaneous squamous cell carcinoma had shrunk and had stopped bleeding. The patient was treated with methylprednisolone, cyclosporine, an...
Source: Experimental and Clinical Transplantation : official journal of the Middle East Society for Organ Transplantation - July 17, 2023 Category: Transplant Surgery Authors: Theodoros Eleftheriadis Ioannis Samaras Antonios Spanos Athanasios Kotsakis Ioannis Stefanidis Source Type: research
Simultaneous integrated or sequential boost to clinically involved lymph nodes in patients with locally advanced cervical cancer treated with definitive chemoradiotherapy
CONCLUSIONS: RT dose escalation provides excellent LC for the clinically involved LNs, even for bulky ones, with a low toxicity profile. Routine LN dissection may not be necessary. However, randomized trials are needed to determine the optimal treatment approach.PMID:37413947 | DOI:10.1016/j.ygyno.2023.06.020
Source: Gynecologic Oncology - July 6, 2023 Category: Cancer & Oncology Authors: Alper Kahvecioglu Ezgi Gurlek Fazli Yagiz Yedekci Sezin Yuce Sari Melis Gultekin Ferah Yildiz Source Type: research
Co-existing squamous cell carcinoma and chronic myelomonocytic leukemia with < em > ASXL1 < /em > and < em > EZH2 < /em > gene mutations: A case report
CONCLUSION: During the treatment and observation of CMML and be vigilant of the growth of multiple primary malignant tumors.PMID:37383892 | PMC:PMC10294182 | DOI:10.12998/wjcc.v11.i15.3643
Source: Clinical Lung Cancer - June 29, 2023 Category: Cancer & Oncology Authors: Lai-Jun Deng Yang Dong Mi-Mi Li Chang-Gang Sun Source Type: research
Analysis of risk factors and management of unexpected intraoperative bleeding during video-assisted thoracic surgery for non-small cell lung cancer: a case-control study
CONCLUSIONS: Although unexpected intraoperative bleeding during VATS is unavoidable, it can be controlled provided that positive and effective hemostasis are achieved. However, prevention is the priority.PMID:37324062 | PMC:PMC10267922 | DOI:10.21037/jtd-23-305
Source: Cancer Control - June 16, 2023 Category: Cancer & Oncology Authors: Wei Chen Kuanzhe Jin Zhanwu Yu Hongxu Liu Source Type: research
Analysis of white-light imaging-based features predictive for determination of lesion depths of superficial flat esophageal squamous cell carcinoma: a retrospective multicenter study from China
CONCLUSIONS: Our study provides six WLI-based morphological features predicting for lesion depth of SESCC. Our findings will make endoscopic evaluation of invasion depth for SESCC more convenient by assessing these profiles.PMID:37291613 | DOI:10.1186/s40001-023-01153-z
Source: Cell Research - June 8, 2023 Category: Cytology Authors: Bin Wang Yadong Feng Jie Song Jifeng Ma Yan Liang Mengjie Li Xiaofen Wang Cui-E Cheng Ruihua Shi Source Type: research
Challenges in Managing Intractable Epistaxis in a Post-nasal Surgery and Radiated Cancer Patient: A Case Report and Literature Review
Indian J Otolaryngol Head Neck Surg. 2023 Apr;75(Suppl 1):1096-1100. doi: 10.1007/s12070-023-03625-4. Epub 2023 Mar 9.ABSTRACTRecurrent epistaxis represents an alarming sign that may suggest a sinister aetiology, especially in patients with previous head and neck malignancy. The recognition of certain potentially life-threatening conditions, namely pseudoaneurysm or tumour recurrence, remains prudence to avoid disastrous repercussion. Nasal endoscopy has become an essential tool in otolaryngology. It can aid identify the underlying cause of epistasis and facilitate therapeutic management. On the other hand, radio imaging i...
Source: Hand Surgery - May 19, 2023 Category: Surgery Authors: S P Goh Rebecca Wilfred Salina Husain I P Tang Source Type: research
Challenges in managing upper gastrointestinal bleeding secondary to primary squamous cell carcinoma of the pancreas: a case report and literature review
CONCLUSIONS: This is the first reported Australian case of pancreatic SCC presenting with upper gastrointestinal bleeding and new-onset diabetes mellitus. Patients with unresectable disease require a multidisciplinary approach to manage complications and improve symptom control. However, there are no standard treatment guidelines and future research is needed in this regard.PMID:37171715 | DOI:10.1186/s40792-023-01663-2
Source: Cancer Control - May 12, 2023 Category: Cancer & Oncology Authors: Colin Chan-Min Choi Yasser Arafat Maryam Shamassi Julian Choi Source Type: research
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
CONCLUSION: Bevacizumab in combination with carboplatin and paclitaxel improved overall response and time to progression in patients with advanced or recurrent non-small-cell lung cancer. Patients with nonsquamous cell histology appear to be a subpopulation with improved outcome and acceptable safety risks.PMID:37126944 | DOI:10.1200/JCO.22.02543
Source: Clinical Lung Cancer - May 1, 2023 Category: Cancer & Oncology Authors: David H Johnson Louis Fehrenbacher William F Novotny Roy S Herbst John J Nemunaitis David M Jablons Corey J Langer Russell F DeVore Jacques Gaudreault Lisa A Damico Eric Holmgren Fairooz Kabbinavar Source Type: research
